WallStreetZenWallStreetZen

NASDAQ: DXCM
Dexcom Inc Stock Ownership - Who owns Dexcom?

Insider buying vs selling

Have Dexcom Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Sadie SternEVP Chief Human Resources2024-03-254,137$140.00
$579.18kSell
Matthew Vincent DolanEVP Strategy Corp Dev2024-03-151,003$131.39
$131.79kSell
Matthew Vincent DolanEVP Strategy Corp Dev2024-03-151,886$129.18
$243.64kSell
Matthew Vincent DolanEVP Strategy Corp Dev2024-03-151,314$130.77
$171.83kSell
Kevin R. SayerPresident CEO and Chairman2024-03-1212,470$131.47
$1.64MSell
Kevin R. SayerPresident CEO and Chairman2024-03-1229,675$134.41
$3.99MSell
Jereme M. SylvainEVP Chief Financial Officer2024-03-1211,661$134.41
$1.57MSell
Sadie SternEVP Chief Human Resources2024-03-12302$131.51
$39.71kSell
Kevin R. SayerPresident CEO and Chairman2024-03-1214,993$132.43
$1.99MSell
Jacob Steven LeachEVP Chief Operating Officer2024-03-1214,639$134.41
$1.97MSell

1 of 10

DXCM insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when DXCM insiders and whales buy or sell their stock.

DXCM Shareholders

What type of owners hold Dexcom Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Vanguard Group Inc11.53%44,467,463$6.20BInstitution
Blackrock Inc8.49%32,726,186$4.56BInstitution
Baillie Gifford Co4.29%16,520,313$2.30BInstitution
State Street Corp4.20%16,198,598$2.26BInstitution
Capital Research Global Investors3.97%15,296,032$2.13BInstitution
Sands Capital Management LLC3.91%15,058,806$2.10BInstitution
Capital World Investors2.41%9,278,685$1.29BInstitution
Geode Capital Management LLC2.31%8,917,255$1.24BInstitution
Fmr LLC2.10%8,112,737$1.13BInstitution
Nuveen Asset Management LLC1.94%7,492,292$1.05BInstitution

1 of 3

DXCM vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
DXCM95.52%4.48%Net SellingNet Selling
EW79.55%1.16%Net SellingNet Buying
ZBH74.93%25.07%Net SellingNet Selling
ALGN84.67%15.33%Net SellingNet Selling
STE95.00%0.91%Net Selling

Dexcom Stock Ownership FAQ

Who owns Dexcom?

Dexcom (NASDAQ: DXCM) is owned by 97.72% institutional shareholders, 4.59% Dexcom insiders, and 0.00% retail investors. Vanguard Group Inc is the largest individual Dexcom shareholder, owning 44.47M shares representing 11.53% of the company. Vanguard Group Inc's Dexcom shares are currently valued at $6.17B.

If you're new to stock investing, here's how to buy Dexcom stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.